China Wearables in Pharma & Biotech Market Size, Share,Trends, Growth Analysis Report, 2031

Name: China Wearables in Pharma & Biotech Market Size, Share,Trends, Growth Analysis Report, 2031
Creator: MarketsandMarkets

Overview Request Sample Pages Request Customization Download PDF

You are viewing: China Wearables in Pharma & Biotech Market analysis

Part of: Wearables in Pharma & Biotech Market (Global)

The China Wearables in Pharma & Biotech Market was valued at $249.8 Million in 2026 and projected to reach to $674.4 Million by 2031, representing a compound annual growth rate of 22.0%. China's wearables in pharma and biotech market is positioned for exceptional growth through 2031, driven by government support for medical device innovation and digital health infrastructure development.

China Wearables in Pharma & Biotech Market (2026-2031) : Size and Share

CAGR of

USD Million

China Wearables in Pharma & Biotech Market Trends and Insights

This represents a compound annual growth rate of 22.0%, significantly outpacing global trends and reflecting China's accelerating digital health adoption and regulatory support for medical devices.
China's market growth is driven by rising healthcare expenditure, increasing prevalence of chronic diseases, and government initiatives promoting remote patient monitoring and precision medicine. The wearables ecosystem in China encompasses smartwatches, patches, rings, and implantable sensors integrated with pharmaceutical and biotech applications.
China's strong manufacturing base, coupled with investments in AI and IoT infrastructure, positions the country as both a major market and production hub for wearable health technologies.
By 2031, China is expected to capture a substantial share of Asia Pacific wearables adoption, supported by expanding telemedicine platforms and integration with China's national health systems. China's regulatory environment, including recent approvals for wearable medical devices and digital health standards, continues to accelerate market penetration across urban and emerging markets.
The convergence of consumer demand, technological innovation, and healthcare system modernization ensures China remains a critical growth engine for the global wearables in pharma and biotech sector through 2031..

Key Market Statistics

CAGR (2026-2031) 22.0% CAGR
Market Size, 2026 ~USD 249.8 Million
Forecast, 2031 ~USD 674.4 Million
Country China

China Wearables in Pharma & Biotech Market Overview

Rapid Market Expansion :

China's wearables in pharma and biotech market is projected to grow from USD 249.8 million in 2026 to USD 674.4 million by 2031, representing a 22% CAGR that significantly exceeds global growth rates of 20.2%.

Government Digital Health Initiative :

China's regulatory framework increasingly supports medical device innovation and digital health adoption, creating favorable conditions for wearable technology integration in pharmaceutical and biotech applications.

Rising Healthcare Digitalization :

Accelerating digital health adoption across China's healthcare system, driven by urbanization, smartphone penetration, and government investment in smart healthcare infrastructure and telemedicine platforms.

Emerging Biotech Ecosystem :

China's growing biotech sector and pharmaceutical companies are increasingly integrating wearable devices for clinical trials, patient monitoring, and drug efficacy tracking, creating substantial market opportunities.

China Wearables in Pharma & Biotech Market Dynamics

The 22% CAGR reflects strong demand from pharmaceutical companies seeking advanced patient monitoring solutions and biotech firms leveraging wearables for clinical research applications. Key growth catalysts include China's aging population requiring chronic disease management, increased R&D investments in smart healthcare technologies, and regulatory streamlining for medical device approvals.
The market will benefit from domestic manufacturing capabilities, rising healthcare expenditure, and integration of wearables with AI-powered health analytics platforms, positioning China as a critical hub for pharma-biotech wearable innovation..

Related Ecosystem

Healthcare It

Top Technologies

Computed Tomography (CT)
Machine Learning
Magnetic Resonance Imaging (MRI)
Natural Language Processing (NLP)
Predictive Analytics

Top Companies

CERNER CORPORATION
PHILIPS HEALTHCARE
Oracle Corporation
GE HealthCare Technologies Inc.
Siemens healthineers

Key Takeaways

China's wearables in pharma and biotech market is valued at USD 249.8 million in 2026 and is forecast to grow to USD 674.4 million by 2031, representing a 22.0% CAGR.
China's market growth outpaces the global average, driven by government digital health initiatives, rising chronic disease prevalence, and expanding telemedicine integration.
China's manufacturing capabilities and AI/IoT infrastructure position the country as a dual hub for both consumption and production of wearable medical technologies.
Regulatory approvals and national health system integration in China are accelerating adoption of remote monitoring and precision medicine applications through 2031.

Wearables in Pharma & Biotech Market Report Scope

Report Metric	Details
Base Year	2026
Fastest Growing Segment	MENTAL HEALTH & BEHAVIORAL HEALTH (Therapeutic Area)
Forecast Period	2026�2031
Growth Rate	CAGR of 20.2% from 2026 to 2031
Largest Segment	PHARMACEUTICAL & BIOTECH COMPANIES (End User)
Market Size Base Year (Billions)	~USD 3.97 (2026)
Revenue Forecast (Billions)	~USD 9.97 (2031)
Segments Covered	Product, Therapeutic Area, Type, Application, End User

China Wearables in Pharma & Biotech Market Report Segmentation

5 segment dimensions are covered across the global market.

By Product

Continuous Glucose Monitors
Fitness Bands
Other Products
Patches
Smart Rings
Smartwatches
Wearable Injectors

By Therapeutic Area

Cardiovascular
Diabetes
Lifestyle & Wellness Improvement
Mental Health & Behavioral Health
Musculoskeletal Disorders/Pain Management
Neurology
Oncology
Other Diseases
Respiratory Disorders
Women�S Health & Reproductive Health

By Type

Atherosclerotic Cardiovascular Diseases/Secondary Prevention
Atrial Fibrillation/Stroke Prevention
Brain Tumor
Breast Cancer
Colorectal Cancer
Heart Failure
Hematologic Malignancies
Hypertension
Leukemia
Lung Cancer
Lymphoma
Multiple Myeloma
Other Hematologic Malignancies
Other Solid Tumors
Phase Ii
Phase Iii
Phase Iv
Prostate Cancer
Pulmonary Hypertension
Solid Tumors
Structural Heart Diseases/Interventional Cardiology

By Application

Chronic Disease Monitoring
Clinical Trials
Drug Discovery
Medication Adherence & Behavioral Support
Personalized & Preventive Digital Therapeutics

By End User

Contract Research Organizations
Healthcare Providers & Clinicians
Other End Users
Pharmaceutical & Biotech Companies

CHINA: WEARABLES IN PHARMA & BIOTECH MARKET, BY END USER, 2024�2031

Segment	2024	2025	2026	2027	2028	2029	2030	2031	CAGR (%)
CONTRACT RESEARCH ORGANIZATIONS	56.9	68.8	83.7	102.3	125.5	154.5	190.9	236.3	23.1
HEALTHCARE PROVIDERS & CLINICIANS	17.2	20.4	24.4	29.3	35.3	42.7	51.8	62.9	20.9
OTHER END USERS	12.7	14.9	17.7	21.1	25.3	30.3	36.4	43.8	19.8
PHARMACEUTICAL & BIOTECH COMPANIES	86.1	103	124	149.8	181.9	221.4	270.5	331.3	21.7
TOTAL	172.8	207.2	249.8	302.6	367.9	448.9	549.5	674.4	22

Target Audience

Pharmaceutical Companies : Evaluate wearable integration opportunities for clinical trials, patient adherence monitoring, and real-world evidence collection in China's rapidly expanding drug development ecosystem.
Biotech Firms & Startups : Understand market sizing, growth potential, and competitive landscape to guide product development, funding strategies, and commercialization timelines for wearable-enabled biotech solutions.
Medical Device Manufacturers : Assess China-specific demand drivers, regulatory requirements, and market opportunities to inform manufacturing expansion, supply chain optimization, and go-to-market strategies.
Healthcare Investors & PE Firms : Leverage detailed market projections and growth drivers to identify investment opportunities in China's high-growth wearables-pharma sector and evaluate portfolio company potential.
Healthcare Technology Consultants : Access comprehensive China market data to advise clients on digital health strategy, wearable adoption roadmaps, and competitive positioning within the pharma-biotech ecosystem.

Key Companies in the China Wearables in Pharma & Biotech Market

Company	HQ	Ownership	Strongest segments

Reasons to Buy this Report

Market-Specific Growth Intelligence : Gain detailed insights into China's 22% CAGR trajectory and understand the unique drivers differentiating this market from global trends, enabling precise investment and expansion strategies.
Regulatory & Policy Landscape : Access comprehensive analysis of China's evolving regulatory framework for medical devices and digital health, critical for navigating approval processes and market entry strategies.
Competitive Positioning Data : Identify key players, market gaps, and competitive dynamics specific to China's pharma-biotech wearables sector to inform product development and partnership decisions.
Demand Forecasting by Segment : Leverage detailed market segmentation and 5-year projections to USD 674.4M to optimize resource allocation and identify high-growth application areas within China's market.
Strategic Market Entry Framework : Obtain actionable recommendations for entering or expanding in China's wearables market, including distribution channels, regulatory pathways, and partnership opportunities with local biotech firms.

Frequently asked questions

What is the current market size of wearables in pharma and biotech in China?

China's wearables in pharma and biotech market is valued at USD 249.8 million in 2026, with expectations to grow significantly through the forecast period.

What is the projected market size for China's wearables in pharma and biotech by 2031?

China's market is projected to reach USD 674.4 million by 2031, representing a 22.0% compound annual growth rate from 2026 to 2031.

What are the primary drivers of growth in China's wearables pharma and biotech market?

Key drivers include government digital health initiatives, rising chronic disease prevalence, expanding telemedicine platforms, and regulatory support for medical device innovation in China.

How does China's wearables market growth compare to global trends?

China's 22.0% CAGR significantly exceeds the global average of 20.2%, reflecting accelerated digital health adoption and stronger regulatory momentum in China.

What types of wearable devices are driving growth in China's pharma and biotech sector?

China's market includes smartwatches, health patches, smart rings, and implantable sensors integrated with pharmaceutical applications and remote patient monitoring systems.

RESEARCH METHODOLOGY

This study involved five major activities to estimate the current size of the wearables in pharma & biotech market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of the wearables in pharma & biotech market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global wearables in pharma & biotech market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital directors, hospital vice presidents, department heads, and critical care specialists) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Wearables in Pharma & Biotech Market
Size, and Share

Note: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million. Other designations include sales managers, marketing managers, and product managers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the wearables in pharma & biotech market. These methods were also used extensively to estimate the size of various subsegments in the market.

The research methodology used to estimate the market size includes the following:

Wearables in Pharma & Biotech Market : Top-Down and Bottom-Up Approach

Data Triangulation

After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the wearables in pharma & biotech market.

Market Definition

The wearables in pharma & biotech market comprise sensor-based, body-worn, or minimally invasive devices and associated digital platforms used to capture continuous physiological and behavioral data across the drug development and healthcare continuum. This includes products such as smartwatches, fitness bands, smart rings, continuous glucose monitors (CGMs), wearable patches, and wearable injectors, which enable real-time monitoring of parameters like heart rate, glucose levels, activity, and treatment adherence. These technologies are applied across a wide range of therapeutic areas, including cardiovascular diseases, oncology (solid tumors and hematologic malignancies), diabetes, mental health, respiratory, neurological, musculoskeletal, and women’s health conditions. The market spans key applications, such as drug discovery, clinical trials (Phase II–IV), medication adherence, chronic disease monitoring, and personalized digital therapeutics, supporting decentralized trials and real-world evidence generation. End users primarily include pharmaceutical and biotechnology companies, healthcare providers, and research organizations, all leveraging wearable technologies to enable data-driven, patient-centric care and more efficient drug development.

Key Stakeholders

Wearable device & biosensor manufacturers (smartwatches, CGMs, patches, smart rings, wearable injectors)
Digital health & software platform providers (mobile apps, cloud platforms, AI analytics)
Component, sensor, & semiconductor technology providers
Pharmaceutical companies
Biotechnology companies
Contract research organizations (CROs)
Clinical trial sponsors & site management organizations
Healthcare providers (hospitals, clinics, remote patient monitoring programs)
Patients & caregivers
Payers & insurers
Regulatory & public health authorities (e.g., US Food and Drug Administration, European Medicines Agency)
Academic institutions & research organizations
Data management, interoperability & cloud infrastructure providers
Cybersecurity & data privacy solution providers
System integrators & IT service providers
Venture capital & private equity firms
Investors & financial institutions
Consulting, regulatory, & compliance service providers

Report Objectives

To define, describe, and forecast the wearables in pharma & biotech market based on product, therapeutic area, application, end user, and region
To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing market growth
To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To strategically analyze the market structure profile of the key players and comprehensively analyze their core competencies
To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, product approvals, and alliances in the market

Customization Options:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of each company.

Geographic Analysis

Further breakdown of the Latin America, Europe, and the Middle East & Africa markets into specific countries

Get the Full Wearables in Pharma & Biotech Market Report

Full forecast, segment splits, and company analysis for all Wearables in Pharma & Biotech Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)